Woodline Partners »

Alnylam Pharmaceuticals shares owned by Woodline Partners

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Woodline Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $42M 92k 456.00
2025-06-30 $203M 623k 326.09
2025-03-31 $42M 157k 270.02
2022-12-31 $23M 95k 237.65